Arthur F. Morelli

Mr. Morelli is a pharmaceutical industry professional with 30+ years of leadership experience at companies such as DuPont Merck Pharma, Elan Biopharmaceuticals, Cardinal Health, Solstice Neurosciences, Inc., Covidien/Mallinckrodt Pharmaceuticals. Mr. Morelli is a co-founder of Solstice Neurosciences, Inc., a venture backed start-up located in South San Francisco for which Art spearheaded the initial capital raise of $43 million. Art is currently leading a $30 million raise for an oncology company in Ohio.

Art currently serves as a Managing Director of Provident Partners, LLC a Connecticut based Corporate Business Development Advisory firm with interests in healthcare and energy businesses, and Art is also a member of the Ohio State University Drug Development Institute Advisory Board.